메뉴 건너뛰기




Volumn 96, Issue 4, 2002, Pages 418-420

Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children

Author keywords

Chemotherapy; Chloroquine resistance; Malaria; Nigeria; Parasite virulence; Pathogenesis; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

EID: 0036652171     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90378-0     Document Type: Article
Times cited : (16)

References (10)
  • 2
    • 0031045669 scopus 로고    scopus 로고
    • Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children
    • Falade, C. O., Salako, L. A., Sowunmi, A., Oduola, A. M. J. & Larcier, P. (1997). Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 58-62.
    • (1997) Transactions of the Royal Society of Tropical Medicine and Hygiene , vol.91 , pp. 58-62
    • Falade, C.O.1    Salako, L.A.2    Sowunmi, A.3    Oduola, A.M.J.4    Larcier, P.5
  • 5
    • 0017903637 scopus 로고
    • Persistence of drug-resistant malaria parasites
    • Rosario, V. E., Hall, R., Walliker, D. & Beale, G. H. (1978). Persistence of drug-resistant malaria parasites. Lancet, i, 185-187.
    • (1978) Lancet , vol.1 , pp. 185-187
    • Rosario, V.E.1    Hall, R.2    Walliker, D.3    Beale, G.H.4
  • 9
    • 84911285091 scopus 로고
    • In vitro micro-test (Mak II) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/pyrimethamine and amodiaquine
    • WHO Geneva: World Health Organization, mimeographed document MAP/87.2
    • WHO (1987). In vitro micro-test (Mak II) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, sulfadoxine/pyrimethamine and amodiaquine. Geneva: World Health Organization, mimeographed document MAP/87.2.
    • (1987)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.